Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin

Aim: To explore the prognostic value of clusterin (CLU) in hepatocellular carcinoma (HCC) patients treated with oxaliplatin (OXA). Methods: Relative expression of plasma CLU mRNA was examined via fluorescence quantitative real-time PCR (qRT-PCR), and CLU protein level in tissue samples was detected...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiumei, Liu, Yongqiang, Qin, Qiong, Zheng, Ti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033306/
https://www.ncbi.nlm.nih.gov/pubmed/32039450
http://dx.doi.org/10.1042/BSR20200071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033306/
https://www.ncbi.nlm.nih.gov/pubmed/32039450
http://dx.doi.org/10.1042/BSR20200071

Ejemplares similares